Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick Guinan

Showing results (21-30 of 36) with videos related to

Pageof 4
Sort By:
In Vivo (Athens, Greece)|November 20, 2012
No compensation in VEGF expression follows antisense suppression of BCL-2 activityMarvin Rubenstein, Courtney M P Hollowell, Patrick Guinan
Therapeutic Advances in Urology|April 5, 2013
Increased expression of the androgen receptor with p300 and interleukin-6 coactivators compensate for oligonucleotide suppression of bcl-2: no increased CREB binding protein or interleukin-4 expressionMarvin Rubenstein, Courtney M P Hollowell, Patrick Guinan
In Vivo (Athens, Greece)|February 21, 2013
No compensation in CD44 stem cell marker following BCL-2 suppression by antisense oligonucleotidesMarvin Rubenstein, Courtney M P Hollowell, Patrick Guinan
Medical Oncology (Northwood, London, England)|April 1, 2003
Inhibition of PC-3 prostate cancer cell growth in vitro using both antisense oligonucleotides and taxolMarvin Rubenstein, Leonid Slobodskoy, Yelena Mirochnik, et al.
In Vivo (Athens, Greece)|February 2, 2011
Bispecific oligonucleotides may induce interferon expression in LNCaP cells enhancing surface antigen expression: effect of intrastrand base pair complementarityMarvin Rubenstein, Courtney M P Hollowell, Patrick Guinan
International Journal of Biometeorology|October 28, 2016
ENSO and PDO-related climate variability impacts on Midwestern United States crop yieldsChasity Henson, Patrick Market, Anthony Lupo, et al.
Medical Oncology (Northwood, London, England)|April 28, 2010
Bax expression remains unchanged following antisense treatment directed against BCL-2Marvin Rubenstein, Courtney M P Hollowell, Patrick Guinan
Medical Oncology (Northwood, London, England)|May 17, 2013
Oligonucleotide suppression of bcl-2 in LNCaP cells is compensated by increased androgen sensitivity, p53 and oncogene activity, and suppressed caspase-3Marvin Rubenstein, Courtney M P Hollowell, Patrick Guinan
In Vivo (Athens, Greece)|November 8, 2015
Suppression of BCL2 by Antisense Oligonucleotides and Compensation by Non-Targeted Genes May Enhance Tumor ProliferationMarvin Rubenstein, Courtney M P Hollowell, Patrick Guinan
Medical Hypotheses|November 25, 2010
Does the prostate retain an endogenous antiviral defense system suggesting a past viral etiology for cancer?Marvin Rubenstein, Courtney M P Hollowell, Patrick Guinan
Pageof 4

Showing results (21-30 of 36) with videos related to

Sort By:
Pageof 4
In Vivo (Athens, Greece)|November 20, 2012
No compensation in VEGF expression follows antisense suppression of BCL-2 activityMarvin Rubenstein, Courtney M P Hollowell, Patrick Guinan
Therapeutic Advances in Urology|April 5, 2013
Increased expression of the androgen receptor with p300 and interleukin-6 coactivators compensate for oligonucleotide suppression of bcl-2: no increased CREB binding protein or interleukin-4 expressionMarvin Rubenstein, Courtney M P Hollowell, Patrick Guinan
In Vivo (Athens, Greece)|February 21, 2013
No compensation in CD44 stem cell marker following BCL-2 suppression by antisense oligonucleotidesMarvin Rubenstein, Courtney M P Hollowell, Patrick Guinan
Medical Oncology (Northwood, London, England)|April 1, 2003
Inhibition of PC-3 prostate cancer cell growth in vitro using both antisense oligonucleotides and taxolMarvin Rubenstein, Leonid Slobodskoy, Yelena Mirochnik, et al.
In Vivo (Athens, Greece)|February 2, 2011
Bispecific oligonucleotides may induce interferon expression in LNCaP cells enhancing surface antigen expression: effect of intrastrand base pair complementarityMarvin Rubenstein, Courtney M P Hollowell, Patrick Guinan
International Journal of Biometeorology|October 28, 2016
ENSO and PDO-related climate variability impacts on Midwestern United States crop yieldsChasity Henson, Patrick Market, Anthony Lupo, et al.
Medical Oncology (Northwood, London, England)|April 28, 2010
Bax expression remains unchanged following antisense treatment directed against BCL-2Marvin Rubenstein, Courtney M P Hollowell, Patrick Guinan
Medical Oncology (Northwood, London, England)|May 17, 2013
Oligonucleotide suppression of bcl-2 in LNCaP cells is compensated by increased androgen sensitivity, p53 and oncogene activity, and suppressed caspase-3Marvin Rubenstein, Courtney M P Hollowell, Patrick Guinan
In Vivo (Athens, Greece)|November 8, 2015
Suppression of BCL2 by Antisense Oligonucleotides and Compensation by Non-Targeted Genes May Enhance Tumor ProliferationMarvin Rubenstein, Courtney M P Hollowell, Patrick Guinan
Medical Hypotheses|November 25, 2010
Does the prostate retain an endogenous antiviral defense system suggesting a past viral etiology for cancer?Marvin Rubenstein, Courtney M P Hollowell, Patrick Guinan
Pageof 4